[2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

C52H68N4O13 — CID 135715852

IUPAC[2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCOc1cccc(CN2CC(C)N(/N=C/c3c4c(O)c5c(O)c(C)c6c(c5c3O)C(=O)C(C)(OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)N4)O6)C(C)C2)c1
InChIInChI=1S/C52H68N4O13/c1-26-15-13-16-27(2)51(64)54-42-37(22-53-56-28(3)23-55(24-29(56)4)25-35-17-14-18-36(21-35)65-11)46(61)39-40(47(42)62)45(60)33(8)49-41(39)50(63)52(10,69-49)67-20-19-38(66-12)30(5)48(68-34(9)57)32(7)44(59)31(6)43(26)58/h13-22,26,28-32,38,43-44,48,58-62H,23-25H2,1-12H3,(H,54,64)/b15-13?,20-19?,27-16?,53-22+
InChIKeyFIRZUNSIGGHGHY-SUQFTMHVSA-N
MW957.13 g/mol
LogP6.69
Rot. Bonds7

About [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

[2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (PubChem CID 135715852) has the molecular formula C52H68N4O13 and a molecular weight of 957.13 g/mol. Its IUPAC name is [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.

Molecular Properties

Compound Name[2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
PubChem CID135715852
Molecular FormulaC52H68N4O13
Molecular Weight957.13 g/mol
Exact Mass956.48
IUPAC Name[2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
SMILESCOc1cccc(CN2CC(C)N(/N=C/c3c4c(O)c5c(O)c(C)c6c(c5c3O)C(=O)C(C)(OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)N4)O6)C(C)C2)c1
InChIInChI=1S/C52H68N4O13/c1-26-15-13-16-27(2)51(64)54-42-37(22-53-56-28(3)23-55(24-29(56)4)25-35-17-14-18-36(21-35)65-11)46(61)39-40(47(42)62)45(60)33(8)49-41(39)50(63)52(10,69-49)67-20-19-38(66-12)30(5)48(68-34(9)57)32(7)44(59)31(6)43(26)58/h13-22,26,28-32,38,43-44,48,58-62H,23-25H2,1-12H3,(H,54,64)/b15-13?,20-19?,27-16?,53-22+
InChIKeyFIRZUNSIGGHGHY-SUQFTMHVSA-N
XLogP6.69
TPSA229.38 Ų
H-Bond Donors6
H-Bond Acceptors16
Rotatable Bonds7
Heavy Atoms69
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500957.13
LogP ≤ 56.69
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hzone_phenol_A(479)', 'substructure': 'N/A'}, {'alert_name': 'keto_naphthol_A(2)', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}, {'alert_name': 'hydroquinone', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The IUPAC name of [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate (CID 135715852) is [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate.
What is the SMILES notation for [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The canonical SMILES for [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is COc1cccc(CN2CC(C)N(/N=C/c3c4c(O)c5c(O)c(C)c6c(c5c3O)C(=O)C(C)(OC=CC(OC)C(C)C(OC(C)=O)C(C)C(O)C(C)C(O)C(C)C=CC=C(C)C(=O)N4)O6)C(C)C2)c1.
What is the InChIKey of [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
The InChIKey is FIRZUNSIGGHGHY-SUQFTMHVSA-N. The full InChI is InChI=1S/C52H68N4O13/c1-26-15-13-16-27(2)51(64)54-42-37(22-53-56-28(3)23-55(24-29(56)4)25-35-17-14-18-36(21-35)65-11)46(61)39-40(47(42)62)45(60)33(8)49-41(39)50(63)52(10,69-49)67-20-19-38(66-12)30(5)48(68-34(9)57)32(7)44(59)31(6)43(26)58/h13-22,26,28-32,38,43-44,48,58-62H,23-25H2,1-12H3,(H,54,64)/b15-13?,20-19?,27-16?,53-22+.
What are the key properties of [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate?
[2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate has a molecular weight of 957.13 g/mol, XLogP of 6.69, 7 rotatable bonds, 6 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [2,15,17,27,29-pentahydroxy-11-methoxy-26-[(E)-[4-[(3-methoxyphenyl)methyl]-2,6-dimethylpiperazin-1-yl]iminomethyl]-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate is sourced from PubChem (CID 135715852), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).